Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults

Figures & data

Table 1 Participant Characteristics

Table 2 ANOVA results for all FMD variables

Table 3 Nutrient Consumption between Supplement Trials

Fig. 1 FMD percentages for each supplement group. Note. Results are presented as mean change post-supplementation; error bars are SD. * = Placebo group is significantly different from the Nitrosigine® group. Ŧ = Placebo group is significantly different than the citrulline malate group

Fig. 2 Scaled FMD percentages for each supplement group. Note. Results are presented as mean change post-supplementation; error bars are SD. * = Placebo group is significantly different from the Nitrosigine® group. Ŧ = Placebo group is significantly different than the citrulline malate group

Fig. 3 Correlation between baseline diameter and FMD%. Note. Results are presented as mean change post-supplementation; error bars are SD. * = Placebo group is significantly different from the Nitrosigine® group. Ŧ = Placebo group is significantly different than the citrulline malate group

Availability of data and materials

The data generated and analyzed during this study are available from the corresponding author upon request.